FDA Rejects Arpida's Iclaprim as Company Seeks a Partner - BioWorld Online PDF Print

... regulators said, adding that there were no drug discontinuations due to treatment emergent renal failure or azotemia, a buildup of nitrogen-type wastes, ...

read more

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.